Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2266 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2197 (97%) | |
Discontinuation Reports |
124 |
|
| To be discontinued: | 4 (3%) | |
| Discontinued: | 118 (95%) | |
| Reversed: | 2 (2%) | |
Late reports |
451 (19%) |
|
Overdue reports |
11 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-09-02 | 2021-10-20 | 145004 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-01-12 | 2022-04-20 | 152599 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-08-18 | 2022-12-28 | 167327 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-03-02 | 2023-07-05 | 186070 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-03-27 | 2023-05-09 | 188061 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-12-04 | 2024-01-31 | 212454 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-01-27 | 2025-05-20 | 248648 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-06-09 | 2025-07-08 | 260000 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2017-03-14 | 2017-04-12 | 2606 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2017-05-17 | 2017-08-02 | 10599 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2017-05-17 | 2017-10-25 | 10602 |
| OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2017-07-11 | 2017-08-02 | 15454 |
| PACLITAXEL INJECTION USP | 6MG | SOLUTION | Resolved | 2017-07-11 | 2017-08-02 | 15457 |
| PACLITAXEL INJECTION USP | 6MG | SOLUTION | Resolved | 2017-07-11 | 2017-10-25 | 15460 |
| PACLITAXEL INJECTION USP | 6MG | SOLUTION | Resolved | 2017-08-07 | 2017-10-25 | 18335 |
| PACLITAXEL INJECTION USP | 6MG | SOLUTION | Resolved | 2023-11-13 | 2023-11-21 | 210067 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-03-14 | 2017-03-28 | 2603 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-05-30 | 2017-07-18 | 11491 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2018-04-19 | 2018-04-30 | 46589 |
| PANTOPRAZOLE SODIUM FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2018-11-26 | 2020-03-30 | 67602 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRAMYCIN INHALATION SOLUTION | 300MG | SOLUTION | Discontinued | 2021-09-02 | 2021-09-02 | 145015 |
| VITAMIN B12 | 100MCG | LIQUID | Discontinued | 2017-06-06 | 2017-07-01 | 12133 |
| ZOFRAN ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-12-08 | 2023-03-14 | 177540 |
| ZOFRAN ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2023-03-14 | 2023-03-14 | 187062 |